Registered Trials
-
EUCTR2020-001038-36, NCT04380701
Phase 1/2Germany
Total Enrollment: 456
Official Trial Registration:
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.